| Delaware (State or other jurisdiction of incorporation) |
77-0054952 (I.R.S. Employer Identification No.) |
| o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| (a) | On September 19, 2006, Adeza Biomedical Corporation (the Company) and Tasman V, LLC (Tasman) amended the Net Industrial Space Lease, dated July 7, 1999, as amended, between Adeza and Tasman (the Lease) to (i) extend the term of the Lease for one year, through September 30, 2007, for a 17,600 square foot facility located at 1240 Elko Drive, Sunnyvale, California with a monthly rental rate of $14,960, and (ii) extend the term of a co-terminus lease for one year, through September 30, 2007, for a 5,000 square foot facility located at 1237 Reamwood Avenue, Sunnyvale, California with a monthly rental rate of $2,500. The Company and Tasman also entered into a new co-terminus lease for a 4,800 square foot facility located at 1239 Reamwood Avenue, Sunnyvale, California with a monthly rental rate of $2,400, which expires on September 30, 2007. |
| ADEZA BIOMEDICAL CORPORATION |
||||
| Date: September 22, 2006 | By: | /s/Mark D. Fischer-Colbrie | ||
| Mark D. Fischer-Colbrie | ||||
| Vice President, Finance and Administration and Chief Financial Officer |
||||